Key Financial Figures (Standalone, Unaudited, ₹ in Lakhs)
Quarter Ended June 30, 2026:
- Revenue from Operations: ₹5.93
- Other Income: ₹53.92
- Total Income: ₹59.85
- Total Expenses: ₹43.55
- Profit before tax: ₹16.30
- Tax Expense: ₹(3.15)
- Net Profit after tax: ₹13.15
- Total Comprehensive Income: ₹13.15
- Paid-up Equity Share Capital: ₹499.61 (Face Value ₹10.00)
- Basic & Diluted EPS: ₹0.26
Comparative Figures:
- Q1 FY2025 (June 30, 2025): Net Profit ₹17.12 lakh, EPS ₹0.34
- Q4 FY2026 (March 31, 2026): Net Profit ₹3.42 lakh, EPS ₹0.01
- Full Year FY2026: Net Profit ₹43.59 lakh, EPS ₹0.81
Segment-wise Performance (Q1 FY2026)
Revenue:
- Healthcare: ₹5.93 lakh
- Rent on Leasehold Land: ₹41.33 lakh
- Others: ₹12.59 lakh
- Total: ₹59.85 lakh
Segment Results (Profit/Loss):
- Healthcare: ₹4.11 lakh
- Rent on Leasehold Land: ₹41.10 lakh
- Others: ₹12.59 lakh
- Total: ₹57.79 lakh
Capital Employed by Segment
- Healthcare: ₹10.50 lakh
- Leasehold Land: ₹(3.74) lakh
- Others: ₹810.43 lakh
- Total: ₹817.20 lakh
Board Approval
- Results approved by Board of Directors and Audit Committee on August 7, 2026
- Signed by Srinivasa Raghavan Mathurakavi Ayyanga, Chairman & Managing Director (DIN: 00090266)
Additional Information
- Company Secretary: Priyanka Sharma
Notes
- Previous periods' figures have been regrouped wherever considered necessary
- Fixed assets are employed for general enterprise and not segmental in nature
- The figures for quarter ended March 31, 2026, are balancing figures between audited annual figures and reviewed nine-month figures